3791 – 3800 of 11779
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Development of a Bioanode for Microbial Fuel Cells Based on the Combination of a MWCNT-Au-Pt Hybrid Nanomaterial, an Osmium Redox Polymer and Gluconobacter oxydans DSM 2343 Cells
(
- Contribution to journal › Article
-
Mark
Type and frequency of side effects during PC6 acupuncture : observations from therapists and patients participating in clinical efficacy trials of acupuncture
(
- Contribution to journal › Article
-
Mark
Highlights of the São Paulo ISEV workshop on extracellular vesicles in cross-kingdom communication
(
- Contribution to journal › Article
-
Mark
Gendering the Legal Subject : Perspectives on the Nordic Field of Law and Gender
2017) p.33-42(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Harmed selves harming others : Vulnerable subjects in criminal legal proceedings
(
- Contribution to journal › Article
-
Mark
An attenuation method for reducing count rate losses in preclinical PET during intratherapeutic imaging
2017) 2016 IEEE Nuclear Science Symposium, Medical Imaging Conference and Room-Temperature Semiconductor Detector Workshop, NSS/MIC/RTSD 2016 2017-January.(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Anmälan av Malou Anderssons avhandling, Grov fridskränkning och grov kvinnofridskränkning. Fridskränkningsbrotten som rättslig konstruktion (ak.avh.), Stockholm, Iustus 2016,
(
- Contribution to journal › Review (Book/Film/Exhibition/etc.)
-
Mark
Genotype-based recall to study metabolic effects of genetic variation : a pilot study of PPARG Pro12Ala carriers
(
- Contribution to journal › Article
-
Mark
Changes in blood volume shunting in patients with atrial septal defects : Assessment of heart function with cardiovascular magnetic resonance during dobutamine stress
(
- Contribution to journal › Article
-
Mark
Factors Predicting the Off-treatment Duration in Patients with Prostate Cancer Receiving Degarelix as Intermittent Androgen Deprivation Therapy
(
- Contribution to journal › Article